Standout Papers

Inferring tumour purity and stromal and immune cell... 2002 2026 2010 2018 5.9k
  1. Inferring tumour purity and stromal and immune cell admixture from expression data (2013)
    Kosuke Yoshihara, Maria Shahmoradgoli et al. Nature Communications
  2. The Cancer Genome Atlas Pan-Cancer analysis project (2013)
    John N. Weinstein, Jun Li et al. Nature Genetics
  3. Use of proteomic patterns in serum to identify ovarian cancer (2002)
    Emanuel F. Petricoin, Ali M. Ardekani et al. The Lancet
  4. mTOR Inhibition Induces Upstream Receptor Tyrosine Kinase Signaling and Activates Akt (2006)
    Kathryn O’Reilly, Qing‐Bai She et al. Cancer Research
  5. Exploiting the PI3K/AKT Pathway for Cancer Drug Discovery (2005)
    Bryan T. Hennessy, Debra L. Smith et al. Nature Reviews Drug Discovery
  6. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth (2011)
    Kristin M. Nieman, Hilary A. Kenny et al. Nature Medicine
  7. A Functional Genetic Approach Identifies the PI3K Pathway as a Major Determinant of Trastuzumab Resistance in Breast Cancer (2007)
    Katrien Berns, Hugo M. Horlings et al. Cancer Cell
  8. The biology of ovarian cancer: new opportunities for translation (2009)
    Robert C. Bast, Bryan T. Hennessy et al. Nature reviews. Cancer
  9. The emerging role of lysophosphatidic acid in cancer (2003)
    Gordon B. Mills, Wouter H. Moolenaar Nature reviews. Cancer
  10. Comprehensive Genomic Analysis Identifies Novel Subtypes and Targets of Triple-Negative Breast Cancer (2014)
    Matthew D. Burstein, Anna Tsimelzon et al. Clinical Cancer Research
  11. PIK3CA is implicated as an oncogene in ovarian cancer (1999)
    Yiling Lu, Wen-Lin Kuo et al. Nature Genetics
  12. Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 (2008)
    Christopher I. Amos, Xifeng Wu et al. Nature Genetics
  13. Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production (2002)
    Makiko Umezu‐Goto, Yasuhiro Kishi et al. The Journal of Cell Biology
  14. State-of-the-art strategies for targeting the DNA damage response in cancer (2018)
    Patrick G. Pilié, Chad Tang et al. Nature Reviews Clinical Oncology
  15. Phosphorylation of β-Catenin by AKT Promotes β-Catenin Transcriptional Activity (2007)
    Dexing Fang, David H. Hawke et al. Journal of Biological Chemistry
  16. The energy sensing LKB1–AMPK pathway regulates p27kip1 phosphorylation mediating the decision to enter autophagy or apoptosis (2007)
    Jiyong Liang, Shan Shao et al. Nature Cell Biology
  17. Phosphorylation and inactivation of glycogen synthase kinase 3 by protein kinase A (2000)
    Xianjun Fang, Yiling Lu et al. Proceedings of the National Academy of Sciences
  18. ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response to ROS (2010)
    Angela Alexander, Jinhee Kim et al. Proceedings of the National Academy of Sciences
  19. Derailed endocytosis: an emerging feature of cancer (2008)
    Yaron Mosesson, Gordon B. Mills et al. Nature reviews. Cancer
  20. Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer (2012)
    Victor Abkevich, Kirsten M. Timms et al. British Journal of Cancer
  21. PARPi Triggers the STING-Dependent Immune Response and Enhances the Therapeutic Efficacy of Immune Checkpoint Blockade Independent of BRCAness (2018)
    Jianfeng Shen, Wei Zhao et al. Cancer Research
  22. ARID1A Deficiency Impairs the DNA Damage Checkpoint and Sensitizes Cells to PARP Inhibitors (2015)
    Jianfeng Shen, Yang Peng et al. Cancer Discovery
  23. Therapy resistance: opportunities created by adaptive responses to targeted therapies in cancer (2022)
    Marilyne Labrie, Joan S. Brugge et al. Nature reviews. Cancer
  24. Development of a nanoparticle-based immunotherapy targeting PD-L1 and PLK1 for lung cancer treatment (2022)
    Moataz Reda, Worapol Ngamcherdtrakul et al. Nature Communications

Immediate Impact

2 by Nobel laureates 53 from Science/Nature 115 standout
Sub-graph 1 of 19

Citing Papers

Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
2021 Standout
Metabolic reprogramming and cancer progression
2020 StandoutScience
10 intermediate papers

Works of Gordon B. Mills being referenced

Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth
2011 Standout
Proteomic and transcriptomic profiling reveals a link between the PI3K pathway and lower estrogen-receptor (ER) levels and activity in ER+ breast cancer
2010
and 5 more

Author Peers

Author Last Decade Papers Cites
Gordon B. Mills 56742 26097 20496 1.0k 87.5k
Peter Carmeliet 52350 14817 27080 720 98.1k
Judah Folkman 62209 24238 29198 391 103.7k
Adrian L. Harris 64085 34514 45128 1.2k 108.2k
Rakesh K. Jain 56025 34052 27248 849 131.8k
Mien‐Chie Hung 42788 27578 13565 740 66.0k
Joan Massagué 94714 46583 22328 356 135.6k
Lewis C. Cantley 103801 27070 29279 702 148.2k
Pier Paolo Pandolfi 61139 12933 22576 449 79.2k
Tyler Jacks 58358 33760 26145 336 86.1k
Chris Sander 67938 13143 25841 304 90.9k

All Works

Loading papers...

Rankless by CCL
2026